Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Colorectal Cancer

Interventions

DRUG

olaparib

400 mg po bid continuously

Trial Locations (8)

Research Site, Los Angeles

Research Site, Palm Springs

Research Site, Aurora

Research Site, Newark

Research Site, New York

Research Site, Philadelphia

Research Site, Nashville

Research Site, Seattle